MedTrace Logo

Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes

NCT03810846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-08-22

No results posted yet for this study

Summary

Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Walking football exercise program

Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Sponsors & Collaborators

  • Federação Portuguesa de Futebol, Portugal

    collaborator UNKNOWN

  • Administração Regional de Saúde do Norte, Portugal

    collaborator OTHER

  • Fédération Internationale de Football Association

    collaborator UNKNOWN

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Romeu Mendes, MD, PhD · EPIUnit - Instituto de Saúde Pública, Universidade do Porto

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2019-01-31
Completion
2019-06-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03810846 on ClinicalTrials.gov